Clinical Trials Browser

Phase 1 × Carcinoma, Non-Small-Cell Lung × naquotinib × Clear all

NCT03082300 2024-11-20

A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02113813 2024-11-14

A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung